One disadvantage of measuring CgA levels is the potential for elevated levels to arise from a variety of diseases or physiological modifications, including heart disease, pulmonary disease, food consumption, etc. The association between circulating CgA level and the tumor extent, overall survival, and tumor response prediction was assessed in a retrospective study involving 102 patients with gastroenteropancreatic NETs. This evidence concerns the gene CGA and heart disorder.